145 related articles for article (PubMed ID: 37527610)
1. Inhibition of cMYC-MAX transcription factors hetero-dimerization with structurally engineered omoMYC to downregulate oncogenic pathways in renal carcinoma.
Li W; Bano F; Khan A; Wei DQ; Alshammari A; Xu B; Wang Y
Comput Biol Med; 2023 Sep; 164():107257. PubMed ID: 37527610
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of compound NSC13728 as Omomyc homodimer stabilizer by molecular dynamics simulation and MM/GBSA free energy calculation.
Gao J; Wang Y; Li K; Zhang J; Geng X
J Mol Model; 2022 Mar; 28(4):92. PubMed ID: 35294626
[TBL] [Abstract][Full Text] [Related]
3. Computational insights into the differentiated binding affinities of Myc, Max, and Omomyc dimers to the E-boxes of DNA.
Dai Y; Zhang J; Wang Y; Liu L; Gao J
J Mol Model; 2022 Sep; 28(10):329. PubMed ID: 36149511
[TBL] [Abstract][Full Text] [Related]
4. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.
Demma MJ; Mapelli C; Sun A; Bodea S; Ruprecht B; Javaid S; Wiswell D; Muise E; Chen S; Zelina J; Orvieto F; Santoprete A; Altezza S; Tucci F; Escandon E; Hall B; Ray K; Walji A; O'Neil J
Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501275
[TBL] [Abstract][Full Text] [Related]
5. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
[TBL] [Abstract][Full Text] [Related]
6. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
7. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
8. OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.
Jung LA; Gebhardt A; Koelmel W; Ade CP; Walz S; Kuper J; von Eyss B; Letschert S; Redel C; d'Artista L; Biankin A; Zender L; Sauer M; Wolf E; Evan G; Kisker C; Eilers M
Oncogene; 2017 Apr; 36(14):1911-1924. PubMed ID: 27748763
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of bevacizumab binding with protein receptors for its potential anticancer activity.
Alsakhen N; Radwan ES; Zafer I; Abed Alfattah H; Shamkh IM; Rehman MT; Shahwan M; Khan KA; Ahmed SA
J Biomol Struct Dyn; 2024 Jan; ():1-21. PubMed ID: 38281913
[TBL] [Abstract][Full Text] [Related]
10. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.
Savino M; Annibali D; Carucci N; Favuzzi E; Cole MD; Evan GI; Soucek L; Nasi S
PLoS One; 2011; 6(7):e22284. PubMed ID: 21811581
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
Beaulieu ME; Jauset T; Massó-Vallés D; Martínez-Martín S; Rahl P; Maltais L; Zacarias-Fluck MF; Casacuberta-Serra S; Serrano Del Pozo E; Fiore C; Foradada L; Cano VC; Sánchez-Hervás M; Guenther M; Romero Sanz E; Oteo M; Tremblay C; Martín G; Letourneau D; Montagne M; Morcillo Alonso MÁ; Whitfield JR; Lavigne P; Soucek L
Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894502
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.
Demma MJ; Hohn MJ; Sun A; Mapelli C; Hall B; Walji A; O'Neil J
FEBS Lett; 2020 May; 594(10):1467-1476. PubMed ID: 32053209
[TBL] [Abstract][Full Text] [Related]
13. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
[TBL] [Abstract][Full Text] [Related]
14. The XBB.1.5 slightly increase the binding affinity for host receptor ACE2 and exhibit strongest immune escaping features: molecular modeling and free energy calculation.
Suleman M; Murtaza A; ; Khan H; Rashid F; Alshammari A; Ali L; Khan A; Wei DQ
Front Mol Biosci; 2023; 10():1153046. PubMed ID: 37325478
[No Abstract] [Full Text] [Related]
15. Methods of Expression, Purification, and Preparation of the c-Myc b-HLH-LZ for Its Biophysical Characterization.
Delattre P; Montagne M; Lavigne P
Methods Mol Biol; 2021; 2318():13-19. PubMed ID: 34019284
[TBL] [Abstract][Full Text] [Related]
16. Multiple Synthetic Routes to the Mini-Protein Omomyc and Coiled-Coil Domain Truncations.
Brown ZZ; Mapelli C; Farasat I; Shoultz AV; Johnson SA; Orvieto F; Santoprete A; Bianchi E; McCracken AB; Chen K; Zhu X; Demma MJ; Lacey BM; Canada KA; Garbaccio RM; O'Neil J; Walji A
J Org Chem; 2020 Feb; 85(3):1466-1475. PubMed ID: 31660743
[TBL] [Abstract][Full Text] [Related]
17. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic activity of the c-Myc protein requires dimerization with Max.
Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
Banerjee A; Hu J; Goss DJ
Biochemistry; 2006 Feb; 45(7):2333-8. PubMed ID: 16475822
[TBL] [Abstract][Full Text] [Related]
20. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]